Report Cover

Global Gabapentin Market Insights and Forecast to 2027


Gabapentin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Capsule
    Tablet

Segment by Application
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others

By Company
    Pfizer
    Assertio Therapeutics
    TEVA
    Mylan
    Arbor Pharma
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Glenmark
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Gabapentin Product Introduction
    1.2 Market by Type
        1.2.1 Global Gabapentin Market Size Growth Rate by Type
        1.4.2 Capsule
        1.4.3 Tablet
    1.3 Market by Application
        1.3.1 Global Gabapentin Market Size Growth Rate by Application
        1.3.2 Epilepsy
        1.3.3 Neuropathic Pain
        1.3.4 Restless Legs Syndrome
        1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Gabapentin Sales Estimates and Forecasts 2016-2027
    2.2 Global Gabapentin Revenue Estimates and Forecasts 2016-2027
    2.3 Global Gabapentin Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Gabapentin Regions by Sales
        2.4.1 Global Top Gabapentin Regions by Sales (2016-2021)
        2.4.2 Global Top Gabapentin Regions by Sales (2022-2027)
    2.5 Global Top Gabapentin Regions by Revenue
        2.5.1 Global Top Gabapentin Regions by Revenue (2016-2021)
        2.5.2 Global Top Gabapentin Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gabapentin Sales by Manufacturers
        3.1.1 Global Top Gabapentin Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Gabapentin Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Gabapentin Sales in 2020
    3.2 Global Gabapentin Revenue by Manufacturers
        3.2.1 Global Top Gabapentin Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Gabapentin Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Revenue in 2020
    3.3 Global Gabapentin Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gabapentin Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Gabapentin Sales by Type
        4.1.1 Global Gabapentin Historical Sales by Type (2016-2021)
        4.1.2 Global Gabapentin Forecasted Sales by Type (2022-2027)
        4.1.3 Global Gabapentin Sales Market Share by Type (2016-2027)
    4.2 Global Gabapentin Revenue by Type
        4.2.1 Global Gabapentin Historical Revenue by Type (2016-2021)
        4.2.2 Global Gabapentin Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Gabapentin Revenue Market Share by Type (2016-2027)
    4.3 Global Gabapentin Price by Type
        4.3.1 Global Gabapentin Price by Type (2016-2021)
        4.3.2 Global Gabapentin Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Gabapentin Sales by Application
        5.1.1 Global Gabapentin Historical Sales by Application (2016-2021)
        5.1.2 Global Gabapentin Forecasted Sales by Application (2022-2027)
        5.1.3 Global Gabapentin Sales Market Share by Application (2016-2027)
    5.2 Global Gabapentin Revenue by Application
        5.2.1 Global Gabapentin Historical Revenue by Application (2016-2021)
        5.2.2 Global Gabapentin Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Gabapentin Revenue Market Share by Application (2016-2027)
    5.3 Global Gabapentin Price by Application
        5.3.1 Global Gabapentin Price by Application (2016-2021)
        5.3.2 Global Gabapentin Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Gabapentin Market Size by Type
        6.1.1 North America Gabapentin Sales by Type (2016-2027)
        6.1.2 North America Gabapentin Revenue by Type (2016-2027)
    6.2 North America Gabapentin Market Size by Application
        6.2.1 North America Gabapentin Sales by Application (2016-2027)
        6.2.2 North America Gabapentin Revenue by Application (2016-2027)
    6.3 North America Gabapentin Market Size by Country
        6.3.1 North America Gabapentin Sales by Country (2016-2027)
        6.3.2 North America Gabapentin Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gabapentin Market Size by Type
        7.1.1 Europe Gabapentin Sales by Type (2017-2027)
        7.1.2 Europe Gabapentin Revenue by Type (2017-2027)
    7.2 Europe Gabapentin Market Size by Application
        7.2.1 Europe Gabapentin Sales by Application (2017-2027)
        7.2.2 Europe Gabapentin Revenue by Application (2017-2027)
    7.3 Europe Gabapentin Market Size by Country
        7.3.1 Europe Gabapentin Sales by Country (2017-2027)
        7.3.2 Europe Gabapentin Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gabapentin Market Size by Type
        8.1.1 Asia Pacific Gabapentin Sales by Type (2018-2027)
        8.1.2 Asia Pacific Gabapentin Revenue by Type (2018-2027)
    8.2 Asia Pacific Gabapentin Market Size by Application
        8.2.1 Asia Pacific Gabapentin Sales by Application (2018-2027)
        8.2.2 Asia Pacific Gabapentin Revenue by Application (2018-2027)
    8.3 Asia Pacific Gabapentin Market Size by Region
        8.3.1 Asia Pacific Gabapentin Sales by Region (2018-2027)
        8.3.2 Asia Pacific Gabapentin Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gabapentin Market Size by Type
        9.1.1 Latin America Gabapentin Sales by Type (2019-2027)
        9.1.2 Latin America Gabapentin Revenue by Type (2019-2027)
    9.2 Latin America Gabapentin Market Size by Application
        9.2.1 Latin America Gabapentin Sales by Application (2019-2027)
        9.2.2 Latin America Gabapentin Revenue by Application (2019-2027)
    9.3 Latin America Gabapentin Market Size by Country
        9.3.1 Latin America Gabapentin Sales by Country (2019-2027)
        9.3.2 Latin America Gabapentin Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Gabapentin Market Size by Type
        6.1.1 Middle East and Africa Gabapentin Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Gabapentin Revenue by Type (2016-2027)
    6.2 Middle East and Africa Gabapentin Market Size by Application
        6.2.1 Middle East and Africa Gabapentin Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Gabapentin Revenue by Application (2016-2027)
    6.3 Middle East and Africa Gabapentin Market Size by Country
        6.3.1 Middle East and Africa Gabapentin Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Gabapentin Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Pfizer Gabapentin Product Description
        11.1.5 Pfizer Related Developments
    11.2 Assertio Therapeutics
        11.2.1 Assertio Therapeutics Corporation Information
        11.2.2 Assertio Therapeutics Overview
        11.2.3 Assertio Therapeutics Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Assertio Therapeutics Gabapentin Product Description
        11.2.5 Assertio Therapeutics Related Developments
    11.3 TEVA
        11.3.1 TEVA Corporation Information
        11.3.2 TEVA Overview
        11.3.3 TEVA Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 TEVA Gabapentin Product Description
        11.3.5 TEVA Related Developments
    11.4 Mylan
        11.4.1 Mylan Corporation Information
        11.4.2 Mylan Overview
        11.4.3 Mylan Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Mylan Gabapentin Product Description
        11.4.5 Mylan Related Developments
    11.5 Arbor Pharma
        11.5.1 Arbor Pharma Corporation Information
        11.5.2 Arbor Pharma Overview
        11.5.3 Arbor Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Arbor Pharma Gabapentin Product Description
        11.5.5 Arbor Pharma Related Developments
    11.6 Novartis
        11.6.1 Novartis Corporation Information
        11.6.2 Novartis Overview
        11.6.3 Novartis Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Novartis Gabapentin Product Description
        11.6.5 Novartis Related Developments
    11.7 Apotex
        11.7.1 Apotex Corporation Information
        11.7.2 Apotex Overview
        11.7.3 Apotex Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Apotex Gabapentin Product Description
        11.7.5 Apotex Related Developments
    11.8 Sun Pharmaceutical
        11.8.1 Sun Pharmaceutical Corporation Information
        11.8.2 Sun Pharmaceutical Overview
        11.8.3 Sun Pharmaceutical Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Sun Pharmaceutical Gabapentin Product Description
        11.8.5 Sun Pharmaceutical Related Developments
    11.9 Aurobindo Pharma
        11.9.1 Aurobindo Pharma Corporation Information
        11.9.2 Aurobindo Pharma Overview
        11.9.3 Aurobindo Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Aurobindo Pharma Gabapentin Product Description
        11.9.5 Aurobindo Pharma Related Developments
    11.10 Intas
        11.10.1 Intas Corporation Information
        11.10.2 Intas Overview
        11.10.3 Intas Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Intas Gabapentin Product Description
        11.10.5 Intas Related Developments
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Pfizer Gabapentin Product Description
        11.1.5 Pfizer Related Developments
    11.12 Marksans Pharma
        11.12.1 Marksans Pharma Corporation Information
        11.12.2 Marksans Pharma Overview
        11.12.3 Marksans Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Marksans Pharma Product Description
        11.12.5 Marksans Pharma Related Developments
    11.13 Glenmark
        11.13.1 Glenmark Corporation Information
        11.13.2 Glenmark Overview
        11.13.3 Glenmark Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Glenmark Product Description
        11.13.5 Glenmark Related Developments
    11.14 Alkem
        11.14.1 Alkem Corporation Information
        11.14.2 Alkem Overview
        11.14.3 Alkem Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Alkem Product Description
        11.14.5 Alkem Related Developments
    11.15 Jiangsu Enhua
        11.15.1 Jiangsu Enhua Corporation Information
        11.15.2 Jiangsu Enhua Overview
        11.15.3 Jiangsu Enhua Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Jiangsu Enhua Product Description
        11.15.5 Jiangsu Enhua Related Developments
    11.16 Jiangsu Hengrui
        11.16.1 Jiangsu Hengrui Corporation Information
        11.16.2 Jiangsu Hengrui Overview
        11.16.3 Jiangsu Hengrui Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.16.4 Jiangsu Hengrui Product Description
        11.16.5 Jiangsu Hengrui Related Developments
    11.17 Sailike
        11.17.1 Sailike Corporation Information
        11.17.2 Sailike Overview
        11.17.3 Sailike Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
        11.17.4 Sailike Product Description
        11.17.5 Sailike Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Gabapentin Value Chain Analysis
    12.2 Gabapentin Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gabapentin Production Mode & Process
    12.4 Gabapentin Sales and Marketing
        12.4.1 Gabapentin Sales Channels
        12.4.2 Gabapentin Distributors
    12.5 Gabapentin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gabapentin Industry Trends
    13.2 Gabapentin Market Drivers
    13.3 Gabapentin Market Challenges
    13.4 Gabapentin Market Restraints

14 Key Findings in The Global Gabapentin Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Gabapentin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Capsule Table 3. Major Manufacturers of Tablet Table 4. Global Gabapentin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Gabapentin Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Gabapentin Sales by Region (2016-2021) & (K MT) Table 7. Global Gabapentin Sales Market Share by Region (2016-2021) Table 8. Global Gabapentin Sales by Region (2016-2021) & (K MT) Table 9. Global Gabapentin Sales Market Share by Region (2022-2027) Table 10. Global Gabapentin Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Gabapentin Revenue Market Share by Region (2016-2021) Table 12. Global Gabapentin Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Gabapentin Revenue Market Share by Region (2022-2027) Table 14. Global Gabapentin Sales by Manufacturers (2016-2021) & (K MT) Table 15. Global Gabapentin Sales Share by Manufacturers (2016-2021) Table 16. Global Gabapentin Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Gabapentin Revenue Share by Manufacturers (2016-2021) Table 18. Gabapentin Price by Manufacturers 2016-2021 (USD/MT) Table 19. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2020) Table 21. Gabapentin Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Gabapentin Product Offered Table 23. Date of Manufacturers Enter into Gabapentin Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Gabapentin Sales by Type (2016-2021) & (K MT) Table 26. Global Gabapentin Sales by Type (2022-2027) & (K MT) Table 27. Global Gabapentin Sales Share by Type (2016-2021) Table 28. Global Gabapentin Sales Share by Type (2022-2027) Table 29. Global Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Gabapentin Revenue Share by Type (2016-2021) Table 32. Global Gabapentin Revenue Share by Type (2022-2027) Table 33. Gabapentin Price by Type (2016-2021) & (USD/MT) Table 34. Global Gabapentin Price Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Gabapentin Sales by Application (2016-2021) & (K MT) Table 36. Global Gabapentin Sales by Application (2022-2027) & (K MT) Table 37. Global Gabapentin Sales Share by Application (2016-2021) Table 38. Global Gabapentin Sales Share by Application (2022-2027) Table 39. Global Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Gabapentin Revenue Share by Application (2016-2021) Table 42. Global Gabapentin Revenue Share by Application (2022-2027) Table 43. Gabapentin Price by Application (2016-2021) & (USD/MT) Table 44. Global Gabapentin Price Forecast by Application (2022-2027) & (USD/MT) Table 45. North America Gabapentin Sales by Type (2016-2021) & (K MT) Table 46. North America Gabapentin Sales by Type (2022-2027) & (K MT) Table 47. North America Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Gabapentin Sales by Application (2016-2021) & (K MT) Table 50. North America Gabapentin Sales by Application (2022-2027) & (K MT) Table 51. North America Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Gabapentin Sales by Country (2016-2021) & (K MT) Table 54. North America Gabapentin Sales by Country (2022-2027) & (K MT) Table 55. North America Gabapentin Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Gabapentin Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Gabapentin Sales by Type (2016-2021) & (K MT) Table 58. Europe Gabapentin Sales by Type (2022-2027) & (K MT) Table 59. Europe Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Gabapentin Sales by Application (2016-2021) & (K MT) Table 62. Europe Gabapentin Sales by Application (2022-2027) & (K MT) Table 63. Europe Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Gabapentin Sales by Country (2016-2021) & (K MT) Table 66. Europe Gabapentin Sales by Country (2022-2027) & (K MT) Table 67. Europe Gabapentin Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Gabapentin Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Gabapentin Sales by Type (2016-2021) & (K MT) Table 70. Asia Pacific Gabapentin Sales by Type (2022-2027) & (K MT) Table 71. Asia Pacific Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Gabapentin Sales by Application (2016-2021) & (K MT) Table 74. Asia Pacific Gabapentin Sales by Application (2022-2027) & (K MT) Table 75. Asia Pacific Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Gabapentin Sales by Region (2016-2021) & (K MT) Table 78. Asia Pacific Gabapentin Sales by Region (2022-2027) & (K MT) Table 79. Asia Pacific Gabapentin Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Gabapentin Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Gabapentin Sales by Type (2016-2021) & (K MT) Table 82. Latin America Gabapentin Sales by Type (2022-2027) & (K MT) Table 83. Latin America Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Gabapentin Sales by Application (2016-2021) & (K MT) Table 86. Latin America Gabapentin Sales by Application (2022-2027) & (K MT) Table 87. Latin America Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Gabapentin Sales by Country (2016-2021) & (K MT) Table 90. Latin America Gabapentin Sales by Country (2022-2027) & (K MT) Table 91. Latin America Gabapentin Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Gabapentin Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Gabapentin Sales by Type (2016-2021) & (K MT) Table 94. Middle East and Africa Gabapentin Sales by Type (2022-2027) & (K MT) Table 95. Middle East and Africa Gabapentin Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Gabapentin Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Gabapentin Sales by Application (2016-2021) & (K MT) Table 98. Middle East and Africa Gabapentin Sales by Application (2022-2027) & (K MT) Table 99. Middle East and Africa Gabapentin Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Gabapentin Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Gabapentin Sales by Country (2016-2021) & (K MT) Table 102. Middle East and Africa Gabapentin Sales by Country (2022-2027) & (K MT) Table 103. Middle East and Africa Gabapentin Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Gabapentin Revenue by Country (2022-2027) & (US$ Million) Table 105. Pfizer Corporation Information Table 106. Pfizer Description and Major Businesses Table 107. Pfizer Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 108. Pfizer Gabapentin Product Table 109. Pfizer Recent Developments Table 110. Assertio Therapeutics Corporation Information Table 111. Assertio Therapeutics Description and Major Businesses Table 112. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 113. Assertio Therapeutics Gabapentin Product Table 114. Assertio Therapeutics Recent Developments Table 115. TEVA Corporation Information Table 116. TEVA Description and Major Businesses Table 117. TEVA Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 118. TEVA Gabapentin Product Table 119. TEVA Recent Developments Table 120. Mylan Corporation Information Table 121. Mylan Description and Major Businesses Table 122. Mylan Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 123. Mylan Gabapentin Product Table 124. Mylan Recent Developments Table 125. Arbor Pharma Corporation Information Table 126. Arbor Pharma Description and Major Businesses Table 127. Arbor Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 128. Arbor Pharma Gabapentin Product Table 129. Arbor Pharma Recent Developments Table 130. Novartis Corporation Information Table 131. Novartis Description and Major Businesses Table 132. Novartis Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 133. Novartis Gabapentin Product Table 134. Novartis Recent Developments Table 135. Apotex Corporation Information Table 136. Apotex Description and Major Businesses Table 137. Apotex Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 138. Apotex Gabapentin Product Table 139. Apotex Recent Developments Table 140. Sun Pharmaceutical Corporation Information Table 141. Sun Pharmaceutical Description and Major Businesses Table 142. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 143. Sun Pharmaceutical Gabapentin Product Table 144. Sun Pharmaceutical Recent Developments Table 145. Aurobindo Pharma Corporation Information Table 146. Aurobindo Pharma Description and Major Businesses Table 147. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 148. Aurobindo Pharma Gabapentin Product Table 149. Aurobindo Pharma Recent Developments Table 150. Intas Corporation Information Table 151. Intas Description and Major Businesses Table 152. Intas Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 153. Intas Gabapentin Product Table 154. Intas Recent Developments Table 155. Amneal Corporation Information Table 156. Amneal Description and Major Businesses Table 157. Amneal Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 158. Amneal Gabapentin Product Table 159. Amneal Recent Developments Table 160. Marksans Pharma Corporation Information Table 161. Marksans Pharma Description and Major Businesses Table 162. Marksans Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 163. Marksans Pharma Gabapentin Product Table 164. Marksans Pharma Recent Developments Table 165. Glenmark Corporation Information Table 166. Glenmark Description and Major Businesses Table 167. Glenmark Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 168. Glenmark Gabapentin Product Table 169. Glenmark Recent Developments Table 170. Alkem Corporation Information Table 171. Alkem Description and Major Businesses Table 172. Alkem Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 173. Alkem Gabapentin Product Table 174. Alkem Recent Developments Table 175. Jiangsu Enhua Corporation Information Table 176. Jiangsu Enhua Description and Major Businesses Table 177. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 178. Jiangsu Enhua Gabapentin Product Table 179. Jiangsu Enhua Recent Developments Table 180. Jiangsu Hengrui Corporation Information Table 181. Jiangsu Hengrui Description and Major Businesses Table 182. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 183. Jiangsu Hengrui Gabapentin Product Table 184. Jiangsu Hengrui Recent Developments Table 185. Sailike Corporation Information Table 186. Sailike Description and Major Businesses Table 187. Sailike Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 188. Sailike Gabapentin Product Table 189. Sailike Recent Developments Table 190. Key Raw Materials Lists Table 191. Raw Materials Key Suppliers Lists Table 192. Gabapentin Distributors List Table 193. Gabapentin Customers List Table 194. Gabapentin Market Trends Table 195. Gabapentin Market Drivers Table 196. Gabapentin Market Challenges Table 197. Gabapentin Market Restraints Table 198. Research Programs/Design for This Report Table 199. Key Data Information from Secondary Sources Table 200. Key Data Information from Primary Sources List of Figures Figure 1. Gabapentin Product Picture Figure 2. Global Gabapentin Market Share by Type in 2020 & 2027 Figure 3. Capsule Product Picture Figure 4. Tablet Product Picture Figure 5. Global Gabapentin Sales Market Share by Application in 2020 & 2027 Figure 6. Epilepsy Figure 7. Neuropathic Pain Figure 8. Restless Legs Syndrome Figure 9. Others Figure 10. Gabapentin Report Years Considered Figure 11. Global Gabapentin Sales 2016-2027 (K MT) Figure 12. Global Gabapentin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Gabapentin Revenue 2016-2027 (US$ Million) Figure 14. Global Gabapentin Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Gabapentin Sales Market Share by Region (2016-2021) Figure 16. Global Gabapentin Sales Market Share by Region (2022-2027) Figure 17. North America Gabapentin Sales YoY (2016-2027) & (K MT) Figure 18. North America Gabapentin Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Gabapentin Sales YoY (2016-2027) & (K MT) Figure 20. Europe Gabapentin Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Gabapentin Sales YoY (2016-2027) & (K MT) Figure 22. Asia-Pacific Gabapentin Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Gabapentin Sales YoY (2016-2027) & (K MT) Figure 24. Latin America Gabapentin Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Gabapentin Sales YoY (2016-2027) & (K MT) Figure 26. Middle East & Africa Gabapentin Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Gabapentin Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Gabapentin Revenue in 2020 Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Gabapentin Sales Market Share by Type (2016-2027) Figure 31. Global Gabapentin Revenue Market Share by Type (2016-2027) Figure 32. Global Gabapentin Sales Market Share by Application (2016-2027) Figure 33. Global Gabapentin Revenue Market Share by Application (2016-2027) Figure 34. North America Gabapentin Sales Market Share by Type (2016-2027) Figure 35. North America Gabapentin Revenue Market Share by Type (2016-2027) Figure 36. North America Gabapentin Sales Market Share by Application (2016-2027) Figure 37. North America Gabapentin Revenue Market Share by Application (2016-2027) Figure 38. North America Gabapentin Sales Share by Country (2016-2027) Figure 39. North America Gabapentin Revenue Share by Country (2016-2027) Figure 40. U.S. Gabapentin Revenue (2016-2027) & (US$ Million) Figure 41. Canada Gabapentin Revenue (2016-2027) & (US$ Million) Figure 42. Europe Gabapentin Sales Market Share by Type (2016-2027) Figure 43. Europe Gabapentin Revenue Market Share by Type (2016-2027) Figure 44. Europe Gabapentin Sales Market Share by Application (2016-2027) Figure 45. Europe Gabapentin Revenue Market Share by Application (2016-2027) Figure 46. Europe Gabapentin Sales Share by Country (2016-2027) Figure 47. Europe Gabapentin Revenue Share by Country (2016-2027) Figure 48. Germany Gabapentin Revenue (2016-2027) & (US$ Million) Figure 49. France Gabapentin Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Gabapentin Revenue (2016-2027) & (US$ Million) Figure 51. Italy Gabapentin Revenue (2016-2027) & (US$ Million) Figure 52. Russia Gabapentin Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Gabapentin Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Gabapentin Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Gabapentin Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Gabapentin Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Gabapentin Sales Share by Region (2016-2027) Figure 58. Asia Pacific Gabapentin Revenue Share by Region (2016-2027) Figure 59. China Gabapentin Revenue (2016-2027) & (US$ Million) Figure 60. Japan Gabapentin Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Gabapentin Revenue (2016-2027) & (US$ Million) Figure 62. India Gabapentin Revenue (2016-2027) & (US$ Million) Figure 63. Australia Gabapentin Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Gabapentin Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Gabapentin Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Gabapentin Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Gabapentin Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Gabapentin Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Gabapentin Sales Market Share by Type (2016-2027) Figure 70. Latin America Gabapentin Revenue Market Share by Type (2016-2027) Figure 71. Latin America Gabapentin Sales Market Share by Application (2016-2027) Figure 72. Latin America Gabapentin Revenue Market Share by Application (2016-2027) Figure 73. Latin America Gabapentin Sales Share by Country (2016-2027) Figure 74. Latin America Gabapentin Revenue Share by Country (2016-2027) Figure 75. Mexico Gabapentin Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Gabapentin Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Gabapentin Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Gabapentin Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Gabapentin Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Gabapentin Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Gabapentin Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Gabapentin Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Gabapentin Revenue Share by Country (2016-2027) Figure 84. Turkey Gabapentin Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Gabapentin Revenue (2016-2027) & (US$ Million) Figure 86. U.A.E Gabapentin Revenue (2016-2027) & (US$ Million) Figure 87. Gabapentin Value Chain Figure 88. Gabapentin Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us